Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

ONCT holding history

Oncternal Therapeutics, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ONCT overviewAll 13F holders of ONCTFull Q2 2026 holdings

Shares (Q4 2024)
0
Sold out in Q4 2024
Value
$0
% of portfolio
0.0%
Quarters held
14
Since Q1 2021
Holdings of ONCT by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20240$00.0%−25,879−100.0%Sold outHolders
Q3 202425,879$34.2K<0.1%00.0%UnchangedHolders
Q2 202425,879$196.7K<0.1%+1,800+7.5%AddedHolders
Q1 202424,079$216.7K<0.1%+24,079NewHolders
Q4 20230$00.0%−475,945−100.0%Sold outHolders
Q3 2023475,945$144.4K<0.1%+60,361+14.5%AddedHolders
Q2 2023415,584$143.4K<0.1%00.0%UnchangedHolders
Q1 2023415,584$326.2K<0.1%00.0%UnchangedHolders
Q4 2022415,584$415.0K<0.1%+5,983+1.5%AddedHolders
Q3 2022409,601$365.0K<0.1%00.0%UnchangedHolders
Q2 2022409,601$454.0K<0.1%−407,025−49.8%ReducedHolders
Q1 2022816,626$1.14M<0.1%+47,812+6.2%AddedHolders
Q4 2021768,814$1.75M<0.1%+6,365+0.8%AddedHolders
Q3 2021762,449$3.18M<0.1%+23,050+3.1%AddedHolders
Q2 2021739,399$3.51M<0.1%+375,483+103.2%AddedHolders
Q1 2021363,916$3.03M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.